Zheng Cao Selected Research

icariside I

9/2022	Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape.
8/2021	Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Cao Research Topics

Disease

22	Neoplasms (Cancer) 09/2022 - 02/2013
10	Inflammation (Inflammations) 09/2022 - 04/2014
6	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 02/2015
6	Pain (Aches) 01/2022 - 11/2013
4	Wounds and Injuries (Trauma) 09/2022 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2009
4	Pre-Eclampsia (Preeclampsia) 05/2021 - 12/2019
4	Infections 01/2021 - 01/2019
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2015
3	Body Weight (Weight, Body) 07/2022 - 05/2016
3	Bone Diseases (Bone Disease) 07/2022 - 12/2015
3	Reperfusion Injury 01/2022 - 10/2017
3	Non-alcoholic Fatty Liver Disease 04/2021 - 06/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020 - 04/2016
3	Intervertebral Disc Displacement (Herniated Disc) 06/2020 - 04/2016
3	Myocardial Infarction 07/2018 - 07/2006
3	Cysts 01/2016 - 10/2013
2	Leukemia 10/2022 - 04/2016
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 12/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Adenocarcinoma of Lung 01/2022 - 01/2021
2	Low Back Pain (Lumbago) 01/2022 - 06/2019
2	Periodontitis 01/2022 - 01/2014
2	Hypoxia (Hypoxemia) 12/2021 - 07/2010
2	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 07/2017
2	Colitis 11/2021 - 10/2013
2	Hemolysis 07/2021 - 11/2002
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2021 - 07/2006
2	Carcinogenesis 01/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Osteoporosis 12/2020 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2019 - 07/2018
2	Neuroinflammatory Diseases 01/2019 - 05/2016
2	Obesity 01/2019 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2017
2	Hypertension (High Blood Pressure) 05/2016 - 02/2014
2	Thrombosis (Thrombus) 05/2009 - 01/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2008 - 07/2006

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2013
11	Proteins (Proteins, Gene)FDA Link 07/2020 - 08/2009
7	Messenger RNA (mRNA)IBA 11/2021 - 04/2016
7	AluminumIBA 12/2020 - 12/2015
5	EnzymesIBA 09/2022 - 01/2016
5	HydrogelsIBA 01/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 10/2022 - 01/2016
4	AntibodiesIBA 09/2022 - 11/2002
4	Aluminum ChlorideIBA 07/2017 - 01/2016
3	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2014
3	AndrogensIBA 01/2022 - 02/2016
3	FibrinIBA 01/2022 - 01/2018
3	LipidsIBA 12/2021 - 01/2021
3	LipopolysaccharidesIBA 11/2021 - 01/2020
3	OligosaccharidesIBA 04/2021 - 01/2016
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 07/2020 - 04/2016
3	Transcription Factors (Transcription Factor)IBA 07/2020 - 07/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2022 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 09/2022 - 04/2021
2	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2022
2	icariside IIBA 09/2022 - 08/2021
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 10/2019
2	SolutionsIBA 01/2022 - 11/2002
2	LigandsIBA 01/2022 - 02/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2021 - 01/2019
2	Cetuximab (Erbitux)FDA Link 12/2021 - 11/2017
2	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 02/2021
2	trichlorosucrose (sucralose)IBA 04/2021 - 02/2021
2	VitaminsIBA 01/2021 - 01/2021
2	AutoantibodiesIBA 11/2020 - 11/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 07/2017
2	AntioxidantsIBA 10/2020 - 01/2019
2	Testosterone (Sustanon)FDA Link 09/2020 - 08/2014
2	Caspase 3 (Caspase-3)IBA 07/2020 - 01/2019
2	Cytochromes c (Cytochrome c)IBA 07/2020 - 01/2019
2	Androgen Antagonists (Antiandrogens)IBA 01/2019 - 02/2016
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2019 - 10/2017
2	Insulin-Like PeptidesIBA 01/2019 - 10/2017
2	QuinazolinesIBA 01/2019 - 10/2017
2	enzalutamideIBA 01/2019 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2017
2	Polysaccharides (Glycans)IBA 01/2016 - 02/2013
2	Proteinase-Activated ReceptorsIBA 04/2014 - 01/2014
2	Wheat Germ AgglutininsIBA 10/2013 - 02/2013
2	ThiazolidinedionesIBA 01/2008 - 07/2006
1	Drug CarriersIBA 10/2022
1	KynurenineIBA 09/2022
1	Kynurenic Acid (Kynurenate)IBA 09/2022
1	xanthurenic acidIBA 09/2022
1	InterferonsIBA 09/2022

Therapy/Procedure

8	Immunotherapy 09/2022 - 01/2021
8	Therapeutics 09/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2015
3	Stents 05/2009 - 07/2006
2	Oral Administration 09/2022 - 08/2021
2	Decompression 01/2022 - 04/2016
2	Diskectomy (Discectomy) 06/2020 - 01/2020
2	Castration 02/2016 - 01/2015
2	Percutaneous Coronary Intervention 05/2009 - 12/2008